LIF and chronic kidney disease: LIF-R's modulation has shown promise in experimental models, where its knockdown mitigates RIF, while its upregulation aggravates it, marking the LIF/LIF-R axis as a potential therapeutic target for kidney fibrosis and CKD progression.